These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effects of hexanic extract of Serenoa repens (Permixon® 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia. Latil A; Pétrissans MT; Rouquet J; Robert G; de la Taille A Prostate; 2015 Dec; 75(16):1857-67. PubMed ID: 26306400 [TBL] [Abstract][Full Text] [Related]
7. Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia. Russo A; Capogrosso P; La Croce G; Ventimiglia E; Boeri L; Briganti A; Damiano R; Montorsi F; Salonia A Expert Opin Drug Saf; 2016 Dec; 15(12):1661-1670. PubMed ID: 27232207 [TBL] [Abstract][Full Text] [Related]
8. Long-term efficacy and safety of a combination of sabal and urtica extract for lower urinary tract symptoms--a placebo-controlled, double-blind, multicenter trial. Lopatkin N; Sivkov A; Walther C; Schläfke S; Medvedev A; Avdeichuk J; Golubev G; Melnik K; Elenberger N; Engelmann U World J Urol; 2005 Jun; 23(2):139-46. PubMed ID: 15928959 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of a formulation containing Serenoa repens, Crocus sativus and Pinus massoniana extracts in men with concomitant LUTS and erectile dysfunction. Quarto G; Cola A; Perdonà S Minerva Urol Nefrol; 2017 Jun; 69(3):300-306. PubMed ID: 27583656 [TBL] [Abstract][Full Text] [Related]
10. An improvement in sexual function is related to better quality of life, regardless of urinary function improvement: results from the IDIProst® Gold Study. Cai T; Morgia G; Carrieri G; Terrone C; Imbimbo C; Verze P; Mirone V; Arch Ital Urol Androl; 2013 Dec; 85(4):184-9. PubMed ID: 24399119 [TBL] [Abstract][Full Text] [Related]
11. Serenoa repens, lycopene and selenium versus tamsulosin for the treatment of LUTS/BPH. An Italian multicenter double-blinded randomized study between single or combination therapy (PROCOMB trial). Morgia G; Russo GI; Voce S; Palmieri F; Gentile M; Giannantoni A; Blefari F; Carini M; Minervini A; Ginepri A; Salvia G; Vespasiani G; Santelli G; Cimino S; Allegro R; Collura Z; Fragalà E; Arnone S; Pareo RM Prostate; 2014 Nov; 74(15):1471-80. PubMed ID: 25154739 [TBL] [Abstract][Full Text] [Related]
12. Do we really need herbal medicine in LUTS/BPH treatment in the 21 Pinggera GM; Frauscher F Expert Opin Drug Saf; 2016 Dec; 15(12):1573-1575. PubMed ID: 27461908 [No Abstract] [Full Text] [Related]
13. [Extract of Serenoa repens in the treatment of benign prostatic hyperplasia and lower urinary tract symptoms]. Amdii RE; Al' Shukri AS Urologiia; 2018 May; (2):114-120. PubMed ID: 29901305 [TBL] [Abstract][Full Text] [Related]
15. [Iscussion on the use of hexane extract of Serenoa repens for combination therapy in patients with LUTS/BPH]. Sivkov AV; Kirpatovskyi VI Urologiia; 2021 Mar; (1):131-139. PubMed ID: 33818949 [TBL] [Abstract][Full Text] [Related]
16. Serenoa repens (saw palmetto): a systematic review of adverse events. Agbabiaka TB; Pittler MH; Wider B; Ernst E Drug Saf; 2009; 32(8):637-47. PubMed ID: 19591529 [TBL] [Abstract][Full Text] [Related]
17. [Our experience of using hexane extract of Serenoa Repens fruit (Permixone) in the treatment of LUTS in clinical practice]. Kuzmenko AV; Gyaurgiev TA; Kuzmenko GA Urologiia; 2022 May; (2):84-89. PubMed ID: 35485819 [TBL] [Abstract][Full Text] [Related]
18. Associations between improvements in lower urinary tract symptoms and sleep disturbance over time in the CAMUS trial. Helfand BT; Lee JY; Sharp V; Foster H; Naslund M; Williams OD; McVary KT; J Urol; 2012 Dec; 188(6):2288-93. PubMed ID: 23083656 [TBL] [Abstract][Full Text] [Related]
19. Observational study: daily treatment with a new compound "Tradamixina" plus serenoa repens for two months improved the lower urinary tract symptoms. Iacono F; Prezioso D; Illiano E; Ruffo A; Romeo G; Amato B BMC Surg; 2012; 12 Suppl 1(Suppl 1):S22. PubMed ID: 23173650 [TBL] [Abstract][Full Text] [Related]
20. Multicentre study on the efficacy and tolerability of an extract of Serenoa repens in patients with chronic benign prostate conditions associated with inflammation. Giulianelli R; Pecoraro S; Sepe G; Leonardi R; Gentile BC; Albanesi L; Brunori S; Mavilla L; Pisanti F; Giannella R; Morello P; Tuzzolo D; Coscione M; Galasso F; D'Angelo T; Ferravante P; Morelli E; Miragliuolo A; Arch Ital Urol Androl; 2012 Jun; 84(2):94-8. PubMed ID: 22908779 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]